- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5403
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mutant p53 as a guardian of the cancer cell ; volume:26 ; number:2 ; day:11 ; month:12 ; year:2018 ; pages:199-212 ; date:2.2019
Cell death and differentiation ; 26, Heft 2 (11.12.2018), 199-212, 2.2019
- Urheber
-
Mantovani, Fiamma
Collavin, Licio
Del Sal, Giannino
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41418-018-0246-9
- URN
-
urn:nbn:de:101:1-2019020109342008519134
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mantovani, Fiamma
- Collavin, Licio
- Del Sal, Giannino
- SpringerLink (Online service)
Ähnliche Objekte (12)
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
The accumulation of mutant p53 in human cancer cells
Cancer therapeutic targeting using mutant–p53-specific siRNAs
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Genomic instability in mutant p53 cancer cells upon entotic engulfment
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Identification and validation of ENTPD5 as a novel target gene of mutant p53 in cancer
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
The accumulation of mutant p53 in human cancer cells
Cancer therapeutic targeting using mutant–p53-specific siRNAs
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Genomic instability in mutant p53 cancer cells upon entotic engulfment
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Identification and validation of ENTPD5 as a novel target gene of mutant p53 in cancer
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
The accumulation of mutant p53 in human cancer cells
Cancer therapeutic targeting using mutant–p53-specific siRNAs
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Genomic instability in mutant p53 cancer cells upon entotic engulfment
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Selective metabolic regulations by p53 mutant variants in pancreatic cancer
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation